Future studies investigating the impact of ICB and other immunotherapies in immune infiltration and function in the TME in these KO tumor models will be important to better understand the impact of these tumor-cell intrinsic APM/IFNγ pathway defects in treatment response, potentially shedding light on alternative therapies for patients unresponsive to ICB. Here, ANPEP is linked to neoplasm.